Henry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
| Revenue (TTM) | $13.60B |
| Gross Profit (TTM) | $4.26B |
| EBITDA | $1.08B |
| Operating Margin | 5.76% |
| Return on Equity | 8.85% |
| Return on Assets | 4.39% |
| Revenue/Share (TTM) | $116.77 |
| Book Value | $28.21 |
| Price-to-Book | 3.14 |
| Price-to-Sales (TTM) | 0.72 |
| EV/Revenue | 0.998 |
| EV/EBITDA | 13.43 |
| Quarterly Earnings Growth (YoY) | 17.10% |
| Quarterly Revenue Growth (YoY) | 6.70% |
| Shares Outstanding | $113.92M |
| Float | $91.71M |
| % Insiders | 0.83% |
| % Institutions | 112.26% |
Volatility is currently expanding
Henry Schein (HSIC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Investors interested in Medical - Dental Supplies stocks are likely familiar with Henry Schein (HSIC) and Straumann Holding AG (SAUHY). But which of these two stocks offers value investors a better bang for their buck right now?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Henry Schein is rated buy with a 12-month price target of $104, reflecting accelerating organic growth, margin expansion, and substantial share repurchases. Q2 2026 results showed 4.6% internal growth, 48 bps gross margin expansion, and a 6.7% reduction in diluted share count, signaling improved business quality. The BOLD+1 cost program targets $125M+ in annual run-rate operating income gains by end-2026, supporting double-digit earnings growth potential into 2027.
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that the Company will present at the following conference in September: Baird Global Healthcare Conference at the InterContinental Hotel, New York City on September 15, 2026, at 12:15 p.m. EDT. Henry Schein's presentations can be heard via live webcast by visiting www.henryschein.com/IRwebcasts. Replays will be available on t.
Henry Schein (HSIC) could produce exceptional returns because of its solid growth attributes.
Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Henry Schein (HSIC) and Straumann Holding AG (SAUHY). But which of these two stocks is more attractive to value investors?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Henry Schein's broader growth, recurring technology revenues and savings plan support its outlook, but leverage and execution risks remain key concerns.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HSIC and any ticker you trade — then tracks every position and per-strategy win rate.
